150M Americans could contract coronavirus

Amy Baxter | | Health Exec | Precision Medicine
coronavirus_2.jpg

The new coronavirus could infect between 70 million and 150 million people in the U.S., according to the attending physician of Congress and the Supreme Court, Brian Monahan. The estimate came the same week as the World Health Organization declared the virus a pandemic.

The figures were reported by NBC News after Monahan briefed the Senate in a closed-door meeting for personnel and administrative staff from both parties. Monahan also advised staffers how to prevent further spread of the virus, including avoiding shaking hands, according to NBC. Staffers are also advised to avoid international treasure if possible.

However, staffers experiencing symptoms of coronavirus, which include fever, cough and shortness of breath, should see their healthcare professionals, as only members of Congress would be tested for COVID-19.

See the full story below:

Congressional doctor expects 70M to 150M people in U.S. will contract coronavir…

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.